Oct 31 2009
VigiLanz Corporation has entered into contracts with Orlando Health, Inc., a group of seven hospitals in Orlando, Florida; and Contra Costa Regional Medical Center in Martinez, California, to license the VigiLanz product suite, consisting of the Dynamic PharmacoVigilance® (DPV) system, the Dynamic PracticeGuidance™ (DPG) system, and the VigiLanz Infection Control Monitor™ (ICM). These clinical decision support solutions were developed by VigiLanz in response to the growing need of hospitals for real time, automated solutions to proactively monitor patients. They identify and prevent adverse drug events, support adherence to clinical best practices, and identify, control and eliminate infectious risks in hospitals.
“VigiLanz is pleased to be acknowledged on both coasts by these well respected health care institutions, as providing the best, most cost effective solutions in the market for these CDSS needs. We look forward to long and productive partnerships,” said David Goldsteen, MD, VigiLanz CEO.